Gastroenteropancreatic neuroendocrine tumors: recommendations of Turkish multidisciplinary neuroendocrine tumor study group on diagnosis, treatment and follow-up

Creative Commons License

YALÇIN Ş., BAYRAM F., ERDAMAR ÇETİN A. S., KÜÇÜK N. Ö., ORUÇ N., Coker A.

ARCHIVES OF MEDICAL SCIENCE, vol.13, no.2, pp.271-282, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 13 Issue: 2
  • Publication Date: 2017
  • Doi Number: 10.5114/aoms.2017.65449
  • Journal Name: ARCHIVES OF MEDICAL SCIENCE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.271-282
  • Keywords: neuroendocrine tumor, guideline, consensus, diagnosis, treatment, ISLET-CELL-CARCINOMA, POSITRON-EMISSION-TOMOGRAPHY, HEPATIC ARTERIAL EMBOLIZATION, CLINICAL-PRACTICE GUIDELINES, ENETS CONSENSUS GUIDELINES, OF-THE-LITERATURE, PHASE-II TRIAL, LIVER METASTASES, ENDOCRINE TUMORS, SOMATOSTATIN RECEPTOR
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

Gastroenteropancreatic neuroendocrine tumors (GEPNETs) are a relatively rare, heterogeneous group of diseases in which important advances have been observed in the diagnosis and treatment as well as in our understanding of the biology and genetics of the disease in recent years. Given the insufficient scientific data available on evidence-based management of GEPNETs and the differences in circumstances in individual countries, a multidisciplinary study group was established to provide guidelines for the management of GEPNETS. This study group consisted of a medical oncologist, endocrinologist, surgeon, pathologist, gastroenterologist, and a nuclear medicine specialist, who aimed to prepare a practical guide in the light of existing scientific data and international guidelines, to be used in common clinical practice.